Clin­i­cal tri­al di­ver­si­ty da­ta show mis­match be­tween en­roll­ment and dis­ease preva­lence, GSK says

A lack of di­ver­si­ty in clin­i­cal tri­als has per­sist­ed de­spite decades of ini­tia­tives to try to turn the tide.

In a re­cent re­view of 17 years of clin­i­cal tri­als, drug­mak­er GSK found that there were some mis­match­es be­tween the de­mo­graph­ics of its US-based tri­als and how preva­lent dis­eases were in those pop­u­la­tions.

The re­sults, the com­pa­ny says, will help GSK and oth­ers de­sign stud­ies that bet­ter rep­re­sent epi­demi­o­log­i­cal rates with­in races and eth­nic­i­ties.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER